| Literature DB >> 31456704 |
Seunghee Won1, Won Kee Lee2, Sung-Wan Kim3, Jung Jin Kim4, Bong Ju Lee5, Je-Chun Yu6, Kyu Young Lee7, Seung-Hwan Lee8, Seung-Hyun Kim9, Shi Hyun Kang10, Euitae Kim11, Young-Chul Chung2,12.
Abstract
Patients with schizophrenia are characterized by deficits in their ability to identify facial expressions of emotion, which are associated with impaired social and occupational function. An understanding of the deficits of facial affect recognition (FAR) early in the course of the illness can improve early intervention efforts to ameliorate potential functional deterioration. This study aimed to investigate the characteristics and correlations between psychotic symptoms and FAR deficits in patients with early-stage schizophrenia using data from the Korean Early Psychosis Cohort Study. Patients with schizophrenia were divided into three groups: 1) severely and markedly ill (n = 112), 2) moderately ill (n = 96), and 3) mildly ill (n = 115). These groups were compared with age- and sex-matched healthy controls. The FAR test was developed using Korean emotional faces from the Korean Facial Expressions of Emotion database. Error rates, correct response times, and nonresponse rates of each subset were calculated. Several psychopathology assessments were also performed. There were significantly more deficits associated with the recognition of anger (p < 0.01), fear (p < 0.01), and contempt (p < 0.01) in the three patient groups than in the healthy control group. In the severely and markedly ill states, all emotions apart from surprise had impaired error rates (p < 0.01 for all analyses). The error rates for happiness, sadness, disgust, surprise, and neutral faces were not significantly different between mildly ill patients and healthy controls. All emotions, except for sadness, had significantly more delayed correct response times in all patient groups than in the healthy controls (p < 0.01 for all analyses). The severity of psychotic symptoms was positively correlated with the happiness and neutral error rates, and depression was positively correlated with the happiness error rates. General social function was negatively correlated with the error rates for happiness, sadness, fear, disgust, and surprise. Overall, our results show that the severity of psychosis and clinical symptoms leads to distinct differences in certain emotions of patients with early-stage schizophrenia. It is considered that these specific emotional characteristics will help deepen our understanding of schizophrenia and contribute to early intervention and recovery of social function in patients with schizophrenia.Entities:
Keywords: early stage; facial affect recognition; psychotic symptom; schizophrenia; severity
Year: 2019 PMID: 31456704 PMCID: PMC6699582 DOI: 10.3389/fpsyt.2019.00564
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Demographic and clinical data of the subjects.
| Variables | Severely and markedly ill statea
| Moderately ill | Mildly ill | Healthy | F/χ² | P | Post hoc* |
|---|---|---|---|---|---|---|---|
|
| 28.07 ± 8.15 | 27.81 ± 8.34 | 27.47 ± 7.39 | 29.31 ± 5.31 | 0.56 | 0.640 | |
|
| 44, 39.27 | 44, 45.83 | 46, 40.00 | 29, 46.77 | 1.67 | 0.645† | |
|
| 53, 47.32 | 36, 37.50 | 45, 39.13 | 7, 11.29 | 23.01 | 0.000† | |
|
| 97, 86.61 | 79, 82.29 | 93, 80.87 | 44, 70.97 | 6.50 | 0.090† | |
|
| 23, 20.54 | 17, 17.90 | 16, 14.04 | 6, 9.68 | 5.29 | 0.508† | |
|
| 15.27 ± 19.35 | 13.24 ± 29.97 | 15.16 ± 27.52 | 0.19 | 0.826 | ||
|
| 59, 52.82 | 48, 50.00 | 46, 40.00 | 4.04 | 0.133 | ||
|
| 4.38 ± 1.04 | 3.62 ± 1.06 | 2.89 ± 1.06 | 57.35 | 0.000 | a > b > c | |
|
| 93.58 ± 17.91 | 66.86 ± 4.87 | 48.19 ± 7.48 | 426.14 | 0.000 | a > b > c | |
|
| 7.50 ± 5.63 | 5.45 ± 4.47 | 2.62 ± 2.47 | 36.69 | 0.000 | a > b > c | |
|
| 49.61 ± 13.69 | 57.65 ± 9.41 | 62.81 ± 12.48 | 34.11 | 0.000 | a < b < c |
p value was calculated using ANOVA. †p value was calculated using chi-square test. *Analysis of variance and Tukey-Kramer’s post-hoc comparison were performed. n, number; DUP, duration of untreated psychosis; ‡chlorpromazine equivalents. CGI-S, Clinical Global Impression-Severity; PANSS, Positive and Negative Syndrome Scale; CDSS, Calgary Depression Scale for Schizophrenia; SOFAS, Social and Occupational Functioning Assessment Scale. adenoted a severely & markedly ill, bdenoted a moderately ill, cdenoted a mildly ill stage groups.
Commission error rates (percent of error trials) in the facial emotion recognition test: comparison of each patient group by disease severity in patients with schizophrenia and healthy controls.
| Variables | Severely and markedly ill statea
| Moderately ill | Mildly ill | Healthy | F |
| Post hoc* |
|---|---|---|---|---|---|---|---|
|
| 0.09 ± 0.01 | 0.05 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 | 9.17 | 0.000 | a > bcd |
|
| 0.26 ± 0.02 | 0.25 ± 0.02 | 0.18 ± 0.02 | 0.18 ± 0.03 | 4.04 | 0.008 | ab > cd |
|
| 0.43 ± 0.03 | 0.39 ± 0.03 | 0.40 ± 0.03 | 0.26 ± 0.04 | 4.87 | 0.003 | abc > d |
|
| 0.75 ± 0.02 | 0.69 ± 0.03 | 0.67 ± 0.02 | 0.53 ± 0.03 | 9.37 | 0.000 | abc > d |
|
| 0.35 ± 0.03 | 0.27 ± 0.03 | 0.22 ± 0.03 | 0.09 ± 0.04 | 10.17 | 0.000 | a > cd |
|
| 0.56 ± 0.03 | 0.57 ± 0.03 | 0.49 ± 0.03 | 0.46 ± 0.04 | 3.41 | 0.018 | ab > d |
|
| 0.12 ± 0.01 | 0.09 ± 0.01 | 0.05 ± 0.01 | 0.11 ± 0.02 | 4.64 | 0.003 | a > c |
|
| 0.09 ± 0.01 | 0.08 ± 0.02 | 0.06 ± 0.01 | 0.03 ± 0.02 | 2.79 | 0.040 | a > d |
Estimated the marginal means over a balanced population. p value was the result of analysis of covariance (ANCOVA) adjusted for education. *Post-hoc comparisons using Tukey-Kramer’s method following a significant ANCOVA. adenoted a severely & markedly ill, bdenoted a moderately ill cdenoted a midly ill states, ddenoted a healthy control groups.
The effect size (Cohen’s d) of the error rates in the facial emotion recognition test: comparison of each patient group and healthy controls.
| Variables | Severely and markedly ill state | Moderately ill state | Mildly ill state |
|---|---|---|---|
|
| -0.655 | -0.462 | -0.243 |
|
| -0.584 | -0.493 | -0.164 |
|
| -0.734 | -0.574 | -0.665 |
|
| -0.921 | -0.674 | -0.582 |
|
| -1.049 | -0.809 | -0.684 |
|
| -0.419 | -0.438 | -0.131 |
|
| -0.091 | 0.070 | 0.433 |
|
| -0.563 | -0.486 | -0.322 |
Omission error rates (percent of nonresponse trials) in the facial emotion recognition test: comparison of each patient group and healthy controls.
| Variables | Severely and markedly ill statea
| Moderately ill | Mildly ill | Healthy | F |
| Post hoc* |
|---|---|---|---|---|---|---|---|
|
| 0.049 ± 0.006 | 0.021 ± 0.007 | 0.010 ± 0.006 | 0.007 ± 0.009 | 7.94 | 0.000 | a > bcd |
|
| 0.092 ± 0.011 | 0.056 ± 0.011 | 0.052 ± 0.010 | 0.014 ± 0.015 | 6.34 | 0.000 | a > cd |
|
| 0.115 ± 0.011 | 0.069 ± 0.012 | 0.048 ± 0.011 | 0.023 ± 0.015 | 9.58 | 0.000 | a > cd |
|
| 0.125 ± 0.013 | 0.069 ± 0.013 | 0.051 ± 0.012 | 0.010 ± 0.017 | 11.12 | 0.000 | a > b > c > d |
|
| 0.107 ± 0.012 | 0.081 ± 0.013 | 0.030 ± 0.012 | 0.007 ± 0.016 | 11.40 | 0.000 | ab > cd |
|
| 0.171 ± 0.016 | 0.108 ± 0.017 | 0.103 ± 0.015 | 0.010 ± 0.021 | 13.07 | 0.000 | a > bcd |
|
| 0.059 ± 0.009 | 0.043 ± 0.009 | 0.015 ± 0.008 | 0.007 ± 0.012 | 6.67 | 0.000 | a > cd |
|
| 0.069 ± 0.011 | 0.040 ± 0.011 | 0.020 ± 0.010 | 0.006 ± 0.014 | 5.47 | 0.000 | a > cd |
Estimated marginal means over a balanced population. p value was the result of analysis of covariance (ANCOVA) adjusted for education. *Post-hoc comparisons using Tukey-Kramer’s method following a significant ANCOVA. adenoted a severely & markedly ill, bdenoted a moderately ill, cdenoted a mildly ill states, ddenoted a healthy control groups.
Correct response time (mm second) in the facial emotion recognition test: comparison of each patient group and healthy controls.
| Variables | Severely and markedly ill statea
| Moderately ill | Mildly ill | Healthy | F |
| Post hoc* |
|---|---|---|---|---|---|---|---|
|
| 1,679.42 ± 30.31 | 1,557.12 ± 26.02 | 1,541.61 ± 29.70 | 1,281.83 ± 41.37 | 19.62 | 0.000 | a > bc > d |
|
| 2,107.11 ± 105.10 | 1,864.01 ± 113.90 | 1,875.64 ± 103.00 | 1,598.04 ± 143.57 | 2.75 | 0.042 | a > d |
|
| 2,063.41 ± 46.52 | 2,057.71 ± 48.95 | 2,061.61 ± 44.28 | 1,666.43 ± 59.98 | 11.83 | 0.000 | abc > d |
|
| 2,151.56 ± 56.20 | 2,133.59 ± 56.15 | 2,120.31 ± 51.64 | 1,808.94 ± 65.06 | 6.69 | 0.000 | abc > d |
|
| 1,898.33 ± 47.76 | 1,804.43 ± 50.44 | 1,817.70 ± 44.61 | 1,386.99 ± 61.72 | 15.43 | 0.000 | abc > d |
|
| 2,252.63 ± 52.73 | 2,284.44 ± 54.76 | 2,319.41 ± 49.33 | 1,986.41 ± 66.74 | 5.83 | 0.000 | abc > d |
|
| 1,775.08 ± 33.59 | 1,703.97 ± 35.86 | 1,706.79 ± 32.78 | 1,464.84 ± 45.66 | 10.15 | 0.000 | abc > d |
|
| 1,594.33 ± 32.29 | 1,572.17 ± 34.14 | 1,536.03 ± 31.20 | 1,216.79 ± 43.48 | 18.42 | 0.000 | abc > d |
Estimated marginal means over a balanced population. p value was the result of analysis of covariance (ANCOVA) adjusted for education. *Post-hoc comparisons using Tukey-Kramer’s method following a significant ANCOVA.adenoted a severely & markedly ill, bdenoted a moderately ill, cdenoted a mildly ill states, ddenoted a healthy control groups.
Correlations between psychopathology and error rates in the facial recognition test within the schizophrenia groups (n = 323).
| Variables | PANSS | PANSS | PANSS | PANSS | PANSS | PANSS | CGI-S | CDSS | SOFAS |
|---|---|---|---|---|---|---|---|---|---|
|
| 0.118* | 0.243† | 0.247† | 0.190† | 0.099 | 0.226† | 0.185† | 0.111* | -0.125* |
|
| 0.105 | 0.179† | 0.168† | 0.103 | 0.089 | 0.165† | 0.079 | 0.084 | -0.200† |
|
| -0.018 | 0.118* | 0.091 | 0.047 | -0.023 | 0.064 | -0.007 | -0.016 | -0.062 |
|
| 0.056 | 0.090 | 0.111* | 0.080 | -0.010 | 0.084 | 0.003 | 0.031 | -0.151† |
|
| 0.093 | 0.122* | 0.157† | 0.134* | -0.010 | 0.128* | 0.036 | -0.031 | -0.102 |
|
| 0.065 | 0.091 | 0.085 | 0.088 | 0.034 | 0.085 | 0.076 | -0.014 | -0.112* |
|
| 0.159† | 0.253† | 0.177† | 0.183† | 0.066 | 0.212† | 0.158† | 0.034 | -0.117* |
|
| 0.069 | 0.054 | 0.136* | 0.166* | 0.048 | 0.109 | 0.079 | 0.041 | -0.087 |
*p < 0.05, †p < 0.01. PANSS, Positive and Negative Syndrome Scale; CGI-S, Clinical Global Impression-Severity; CDSS, Calgary Depression Scale for Schizophrenia; SOFAS, Social and Occupational Functioning Assessment Scale.